Article
Impact of non-genetic heterogeneity of BRAF-mutant colon cancer organoids on growth kinetics, drug sensitivity and Wnt dynamics.
International journal of cancer - 15 Jul 2026
Zieger Viktoria, Woehr Ellen, Traichel Jasmin, Brummer Tilman, Zengerle Roland, Kartmann Sabrina, Zimmermann Stefan
Abstract excerpt
Patient-derived organoid (PDO) models are powerful systems for studying tumor biology and drug response. By retaining genetic, histological, and functional characteristics of the original tumor, including intra- and interpatient heterogeneity, they provide powerful tools to investigate therapy resistance. While genomic profiling is well established in organoid-based screening, non-genetic parameters such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
